Exclusive

Publication

Byline

Location

US Patent Issued to STINGINN on April 14 for "Substituted 1,2,4-triazoles and methods of use" (Florida Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,704, issued on April 14, was assigned to STINGINN LLC (Miami). "Substituted 1,2,4-triazoles and methods of use" was invented by Glen N Bar... Read More


US Patent Issued to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION on April 14 for "Heat shock protein modulators and anti-Huntington disease therapeutic agents" (Pennsylvania Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,705, issued on April 14, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh). "Heat shock... Read More


US Patent Issued to NAN YA PLASTICS on April 14 for "Method for manufacturing low-viscosity hardener" (Taiwanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,706, issued on April 14, was assigned to NAN YA PLASTICS Corp. (Taipei, Taiwan). "Method for manufacturing low-viscosity hardener" was inv... Read More


US Patent Issued to KARE CHEMICAL TECHNOLOGIES on April 14 for "Cannabinoid derivatives, precursors and uses" (Canadian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,707, issued on April 14, was assigned to KARE CHEMICAL TECHNOLOGIES INC. (Mississauga, Canada). "Cannabinoid derivatives, precursors and u... Read More


US Patent Issued to Apoapsis Holdings on April 14 for "Prodrug compounds of 3,4-methylenedioxymethamphetamine (MDMA) and methods of synthesizing the same" (Canadian, American Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,708, issued on April 14, was assigned to Apoapsis Holdings LLC (Longmont, Colo.). "Prodrug compounds of 3,4-methylenedioxymethamphetamine ... Read More


US Patent Issued to CRINETICS PHARMACEUTICALS on April 14 for "Nonpeptide somatostatin type 5 receptor agonists and uses thereof" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,709, issued on April 14, was assigned to CRINETICS PHARMACEUTICALS INC. (San Diego). "Nonpeptide somatostatin type 5 receptor agonists and... Read More


US Patent Issued to LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE on April 14 for "Beta-catenin and b-cell lymphoma 9 (BCL9) inhibitors" (Florida Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,710, issued on April 14, was assigned to LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.). "Beta-catenin and b-cell lym... Read More


US Patent Issued to KEZAR LIFE SCIENCES on April 14 for "Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors" (California Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,711, issued on April 14, was assigned to KEZAR LIFE SCIENCES INC. (South San Francisco, Calif.). "Triazacyclododecansulfonamide (TCD)-base... Read More


US Patent Issued to Hoffmann-La Roche on April 14 for "Amino-pyrimidine amides" (French, Swiss, German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,712, issued on April 14, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Amino-pyrimidine amides" was invented by Angelica B... Read More


US Patent Issued to Hutchmed on April 14 for "Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,713, issued on April 14, was assigned to Hutchmed Ltd. (Shanghai). "Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethy... Read More